AU662760B2 - Determining brain activity including the nature of brain lesions by electroencephalography - Google Patents

Determining brain activity including the nature of brain lesions by electroencephalography Download PDF

Info

Publication number
AU662760B2
AU662760B2 AU25161/92A AU2516192A AU662760B2 AU 662760 B2 AU662760 B2 AU 662760B2 AU 25161/92 A AU25161/92 A AU 25161/92A AU 2516192 A AU2516192 A AU 2516192A AU 662760 B2 AU662760 B2 AU 662760B2
Authority
AU
Australia
Prior art keywords
data
frequency domain
representative
relative
energy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU25161/92A
Other versions
AU2516192A (en
Inventor
Ian A. Cook
Andrew F Leuchter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2516192A publication Critical patent/AU2516192A/en
Application granted granted Critical
Publication of AU662760B2 publication Critical patent/AU662760B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/369Electroencephalography [EEG]
    • A61B5/372Analysis of electroencephalograms
    • A61B5/374Detecting the frequency distribution of signals, e.g. detecting delta, theta, alpha, beta or gamma waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/40Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia

Description

OPI DATE 16/03/93 AOJP DATE 27/05/93 APPLN. ID 25161/92 II 11 ll l11111 PCT NUMBER PCT/US92/06789 AU9225161 li- IrM 4 .iJNL t-XL rrL, tntiU'INV ruoDLionCUr UiNLjK irr nc rl IN I LAUURLKAIIlUIN I KhA I Y (FCT) (51) International Patent Classification 5 (11) Intenational Publication Number: WO 93/03670 A61B 5/0476 Al (43) International Publication Date: 4 March 1993 (04.03.93) (21) International Application Number: PCT/US92/06789 (74) Agents: BERMAN, Charles; Sheldon Mak, 10990 Wilshire Boulevard, Suite 440, Los Angeles, CA 90024 (US) (22) International Filing Date: 12 August 1992 (12.08.92) et al.
Priority data: (81) Designated States: AU, CA, JP, European patent (AT, BE, 745,872 16 August 1991 (16.08.91) US CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL,
SE).
(71) Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US/US]; University of California, Los Published Angeles, 405 Hilgard Avenue, 1400 Ueberroth Building, With international search report.
Los Angeles, CA 90024-1406 (US).
(72) Inventors: LEUCHTER, Andrew, F. 134 Carmelina Avenue, Los Angeles, CA 90049 COOK, lan, A. 219 Tower Drive, Beverly Hills, CA 90211 (US).
(54)Title: DETERMINING BRAIN ACTIVITY INCLUDING THE NATURE OF BRAIN LESIONS BY ELECTRO-
ENCEPHALOGRAPHY
(57) Abstract s 2 4 Determining brain lesions by quantified electroencephalography is ef- 6 zo2 fected by obtaining absolute power data in a primary frequency domain for a 2 brain region. Power data in the primary frequency domain in relation to power '2 in a secondary frequency domain is determined. The two sets of data are relat- EE UNIT ed to obtain a value representative of the electrical ouput in the brain region. CONENI AALOC SIc The representative value is compared to as selected base value and quantified NICROCOMPUTER departures are mapped topographically. This map is used to identify and as- CoTVE sess lesions associated with disorders and afflictions including dementia and DICITAL 0A demyelinating diseases. Mapping is used to determine activation during tasksr IF such as motor and memory task, cognitive processing or other conditions, andPOWER SPECT also to assess the level of perfusion of the brain. The apparatus includes elec- SOLUTE POWER RELATE POWER trodes (11, 12, 13, 14, and 15) attached to the head of a patient. A ESTARUSIINS IIAXIU ESTABUSHINS MAINUI ABSOLUTE POWER VALUES RELATIVE POWER VALUES (ARATIO) (RRATIO) I ESTABUSV I ESTABUS" MIDPOINT VALUE MIDPOINT VALUE ESTA3USH SUPRA-.
INFRA-MIDPOINT
SELECTED FREOUENCY BAND SELECTED FREQUENCY BAND DISCOANCE .0 6 CONCORDANCE
COROANCE
MAP
I_ i L- WO 93/03670 PCT/US92/06789 DETERMINING BRAIN ACTIVITY INCLUDING THE NATURE OF BRAIN LESIONS BY ELECTROENCEPHALOGRAPHY Portions of the work leading to this application were developed under a grant of the National Institute of Mental Health (NIMH) under Grant No.
MH 40705. The NIMH may have rights in this application.
BACKGROUND
Diagnosing disorders and afflictions in the human brain with non-invasive procedures is important medically and scientifically. Determining activation during tasks, cognitive processing, or in other conditions as evidenced by brain activity and through non-invasive procedures is also most valuable.
Assessing, non-invasively, when the brain is experiencing normal activity provides additional valuable data.
This invention relates to determining the nature of brain lesions using quantitative electrophysiology. In particular, the invention relates to analyzing electroencephalographic information in a manner to permit assessment of the nature of brain lesions. The invention is further directed to give a characterization of afflictions such as dementia, being selective for multi-infarct dementia or Alzheimer's disease, Pick's disease and demyelinating diseases such as multiple sclerosis.
a The invention is also directed to 'dtermining activation tasks by using quantitative electrophysiology, particularly the activation of specific brain regions rendered in mental processing such as motor and memory activity, cognitive processing or other conditions.
Brain imaging used by physicians in clinical practice includes structural imaging and functional I WO 93/03670 PCT/US92/06789 2 j imaging. Structural imaging is effected by computed axial tomography (CAT) scanning or magnetic resonance imaging (MRI) scanning. Functional imaging is effected by positron emission tomography (PET), single photon emission computed tomography (SPECT) or electroencephalography (EEG).
Structural imaging is performed for determining the location of a brain tumor or other kind of gross structural alteration of the brain. Functional imaging tests are performed to determine functional alteration in the brain where there may not be significant structural alteration. These broad categories of tests are complementary. A physician evaluating a neurological or psychiatric illness could perform a test from both categories to assess and/or diagnose a patient's condition.
The present invention particularly concerns functional imaging.
PET scanning measures brain metabolism and can identify areas that are hypoactive. SPECT scanning measures cerebral blood flow, which is an indirect measure of metabolism and therefore brain function. Both of these technologies yield useful physiological information. For example, Alzheimer's disease presents with hypometabolism or hypoperfusion of the parietal lobes bilaterally and multi-infarct dementia presents with multiple foci of hypometabolism and hypoperfusion. PET and SPECT scanning are expensive, requiring investments of millions of dollars initially. Also requiied are many hours of technician time per test and the production and injection of radionuclides into a patient.
EEG brain mapping is relatively less expensive and can be performed without the need for radionuclides.
Technician time for performing the scan also is less costly. A disadvantage of EEG mapping, however, is that I P_ 1 1 SWO 93/03670 PCT/US92/06789 3 it has not been possible to analyze the information obtained by the electroencephalogram to diagnose and assess effectively different conditions of the brain, and Sthus diseases and disorders of the brain.
Information which is obtainable from an EEG includes conventional EEG data representative of electrical activity in different brain regions. When this data is digitized and processed as in quantitative EEG it is possible to obtain topographical brain mapping of electrical activity in different brain regions. From a qEEG unit, it is also possible to obtain measurements of absolute power and relative power, and evoked potentials. Quantitative EEG techniques represent an advance over traditional EEG methods because they permit the detection of trends which are difficult or impossible. to discern by direct visual inspection of the EEG voltage tracings. Previous efforts to generate images depicting quantitative EEG data have had limited clinical applicability because they have not been shown convincingly to be associated with specific clinical syndromes or diagnoses; for example, the presence of a qEEG brain map of regions with large amounts of power in the delta band may reflect an electrophysiologic encephalopathy from many diseases, without distinguishing between them.
A shortfall of all these EEG and qEEG data and information which are analyzed independently is the inability to provide information regarding brain physiology that is substantially equivalent to information from PET or SPECT scans.
SUMMARY
By the present invention, there is provided a method and means of minimizing the disadvantages of EEGs 4 and providing for enhanced techniques of quantitative EEG analysis.
The invention provides for information about brain electrical function i that can be associated with specific diseases and syndromes and thus can assist in establishing different diagnoses.
According to the invention the invention provides a method of determining the electrical output of a brain region in the head of a subject comprising obtaining first data representative of energy in the brain region in a primary frequency domain, determining second data representative of energy in the primary frequency domain substantially simultaneously relative to the energy in a secondary frequency domain, and relating the first data with the second data thereby obtaining a value representative of electrical output in the brain region.
The first data and the second data are then related, thereby obtaining a representative value of the electrical output in the brain region. This relationship is established on the combination of the first data and the second data.
,,The representative value obtained by this combination of first data and second data is a concordance value or a discordance value.
Such values are quantified relative to the departure of the first data and second data from a selected base value. The concordance value is indicated by departure of both the first data and the second data in a first direction from a selected base value. A discordance value is indicated by departure of the first data and the second data in opposite directions from a selected base value. In addition to the concordance and discordance states, there is a state of "no concordance" and "no discordance". This is referred to as "no cordance". This condition also provides information about brain activity.
Preferably, the concordance value and discordance value are quantified and mapped topographically 115/95JB25161.NP,4 p.- WO 93/03670 PCT/US92/06789 1 V relative to the brain region. The mapping is effected in selected frequency domains and is employed to assess and assist diagnosing disorders and afflictions characterized by lesions in the brain. This mapping is referred to as cordance brain mapping.
The first data and second data are selectively absolute power and relative power, respectively.
Absolute power is a determination of the intensity of electric activity in a given frequency domain in a brain region. Relative power is a measure of the proportion of electrical activity in a given frequency domain in a brain region. Cordance mapping represents an enhancement of quantified EEG methods that adds significant sensitivity for at least the detection of deep or cortical brain lesions, The invention provides for information about brain electrical function that can be associated with specific diseases and thus can distinguish between different diagnoses.
Further, the invention provides for information about brain function associated with activation tasks, such tasks being selectively a cognitive, perceptual, emotional, specific memory task, a motor task, or cognitive processing. Preferably, the information is obtained from a concordance or discordance value. This information is selectively the activation, deactivation, or absence of activation effect during a task.
In a further preferred form of the invention, concordance in a selected frequency domain is associated with normal i rfusion in the brain. Such a concordance value correlates with both the mean perfusion of tissue and the volume of tissue with specified perfusion characteristics.
I
WO 93/03670 PCr/US92/06789 f 6 The invention covers the method of determining the electrical output in regions of the brain, apparatus for providing the determination, and the use of such methodology and apparatus to perform assessments and characterization of the human brain.
The invention is now further described with reference to the accompanying drawings.
DRAWINGS
Figure 1 includes three views of scans of a patient with multi-infarct dementia. Figure 1A is a brain map illustrating discordance in the two frequency bands in a linked ear montage; Figure lB is an MRI scan illustrating the same brain region; and Figure 1C is a SPECT scan illustrating the same brain region as the brain map.
Figure 2 includes three views of scans of the same patient as in Figure 1. Figure 2A is a brain map illustrating concordance in the one frequency band in a linked ear montage; Figure 2B is an MRI scan illustrating the same brain region; and Figure 2C is a SPECT scan illustrating the same brain region.
Figure 3 includes three views of scans of a patient with dementia of unknown etiology. Figure 3A is a brain map illustrating discordance in the one frequency band in a linked ear montage; Figure 3B is an MRI scan illustrating the same brain region; and Figure 3C is an MRI scan illustrating the same brain region.
Figure 4 includes two views of scans of a patient with Alzheimer's disease. Figure 4B is a brain map illustrating discordance in the one frequency band in a reformatted bipolar montage, herein termed bipolar WO 93/03670 PCT/US92/06789 7 montage; Figure 4A is a PET scan illustrating the same brain region.
Figure 5 includes two views of scans of a patient with Pick's disease. Figure 5B is a brain map illustrating discordance in the one frequency band in a bipolar montage; Figure 5A is a SPECT scan illustrating the same brain region.
io Figure 6 are further brain scans of the patient illustrated in Figure 5. In Figure 6A, there is illustrated absolute power in four frequency bands; Figure 6B illustrates relative power in four frequency bands; Figure 6C illustrates discordance maps in four frequency bands; and Figure 6D illustrates concordance maps in four frequency bands. Figures 6A and 6B are obtained in a linked ear montage; Figures 6C and 6D are obtained in a bipolar montage.
Figure 7 includes two views of scans of a patient with multiple sclerosis. Figure 7B is a brain map illustrating discordance in the one frequency band in a bipolar montage; Figure 7A is an ,IRI scan illustrating the same brain region.
Figure 8 includes two views of scans of a control subject with white-matter disease. Figure 8B is a brain map illustrating discordance in the one frequency band in a bipolar montage; Figure 8A is a SPECT scan illustrating the same brain region.
Figure 9 is a schematic of major components illustrating the data processing and flow to obtain the cordance map from the electrical output in a brain region.
i WO 93/03670 PCr/US92/06789" 8 Figure 10 is a block schematic illustrating the relationship of a patient relative to apparatus for obtaining cordance mapping.
Figure 11 are brain scans of the patien illustrated in Figure 1 and 2. In Figure 11A, there is illustrated absolute power in four frequency bands; Figure 11B illustrates relative power in four frequency bands; Figure 11C illustrates discordance maps in four frequency bands; and Figure 11D illustrates concordance maps in four frequency bands. Figures 11A and 11B are obtained in a linked ear montage; Figures 11C and 11D are obtained in a bipolar montage.
Figure 12 are brain scans of the patient illustrated in F'igure 1 and 2, the relationship being in a linked ear montage. In Figure 12A, there is illustrated absolute power in four frequency bands; Figure 12B illustrates relative power of four frequency bands; 13 Figure 12C illustrates discordance maps in four frequency bands; and Figure 12D illustrates concordance maps in four frequency bands.
Figure 13 is an alternative preferred version of Figure 1 set up with an improved computer program and with data obtain.id in the bipolar montage. Delta and theta maps of Figure 1 have been replaced with beta and theta maps as indicated.
Figure 14 is an alternative preferred version of Figure 2 set up with an improved computer program and with data obtained in the bipolar montage. A delta map of Figure 2 has been replaced with a theta map as indicated.
Figure 15 is an alternative preferred version of Figure 3 set up with an improved computer program and c. U: I -ri/u U MAA Wi 9 T/US 92/06789 with data obtained in the bipolar montage. A delta map of Figure 3 has been replaced with a beta map as indicated.
Figure 16 is an alternative preferred version of Figure 4 set up with an improved computer program and with data obtained in the bipolar montage. A delta map of Figure 4 has been replaced with a beta map as indicated.
Figure 17 is an alternative preferred version of Figure 5 set up with an improved computer program and with data obtained in the bipolar montage. A new theta map is indicated.
Figure 18 is an alternative preferred version of Figure 6 set up with an improved computer program and with data obtained in the bipolar montage. New C (discordance) and D (concordance) maps are indicated.
Figure 19 is an alternative preferred version of Figure 7 set up with an improved computer program and with data obtained in the bipolar montage. A delta map of Figure 7 is replaced with a theta map as indicated.
Figure 20 is an alternative preferred version of Figure 8 set up with an improved computer program and with data obtained in the bipolar montage. A new theta -ap is indicated.
Figure 21 is an alternative preferred version of Figure 11 set up with an improved computer program and with data obtained in the bipolar montage. A new C (discordance) and D (concordance) are indicated.
Figures 22A, 22B and 22C are alpha concordance and discordance maps for the three CON subjects with the S s SUBSTITUTE SHEET N IPE
A
US
L* _i J 16 Bgc'd PCT/PTO 0 1 MM M PCT/US 92/06789 best performance on the reminiscence and hypermnesia paradigm (EH, LD, and LG). Subjects are identified on the left side, along with the ratio of correctly recalled/not recalled items on the reminiscence paradigm (the CC/NN ratio). The higher the ratio, the better the performance. The maps from the CC and NN condition for each subject are displayed separately, with concordance maps in the left column and discordance maps in the right column. Each map represents the head as viewed from above, with frontal regions at the top. Concordance and discordance are mapped separately but on the same colorgraphic scale, where black is intense cordance (either concordance or discordance), there are intermediate levels of cordance, and'white is a value of zero (neither concordance or discordance, but a no cordance state).
Figures 23A and 23E are alpha concordance and discordance maps for the two CON subjects with the poorest performance on the reminiscence and hypermnesia paradigm (MG and AS). Subjects are identified on the left side, along with the ratio of correctly recalled/not recalled items on the reminiscence paradigm (the CC/NN ratio). The higher the ratio, the better the performance. The maps from the CC and NN condition for each subject are displayed separately, with concordance maps in the left column and discordance maps in the right column. Each map represents the head as viewed from above, with frontal regions at the top. Concordance and discordance are mapped separately but on the same colorgraphic scale, where black is intense cordance (either concordance or discordance), and there are intermediate levels of cordance, and white is a value of zero (neither concordance or discordance, but a no cordance state).
f SUBSTITUTE
SHEET
IPEA/U8 A92/06789 11 Figures 24A and 24B are alpha concordance and discordance maps for two MDE subjects on the reminiscence and hypermnesia paradigm (CM and AM). Subjects are identified on the left side, along with the ratio of correctly recalled/not recalled items on the reminiscence paradigm (the CCiNN ratio). The higher the ratio, the better the performance. The maps from the CC and NN condition for each F'lbject are displayed separately, with concordance maps in the left column and discordance maps in the right column. Each map represents the head as viewed from above, with frontal regions at the top.
Concordance and discordance are mapped separately but on the same colorgraphic scale, where black is intense cordance (either concordance or discordance), there are intermediate levels of cordance, and white is a value of zero (neither concordance or discordance, but a no cordance state).
Figures 25A and 25B are alpha concordance and discordance maps for two MDE subjects on the reminiscence and hypermnesia paradigm (SC and LM). Subjects are identified on the left side, along with the ratio of correctly recalled/not recalled items on the reminiscence paradigm (the CC/NN ratio). The higher the ratio, the better the performance. The maps from the CC and NN condition for each subject are displayed separately, with concordance maps in the left column and discordance maps in the right column. Each map represents the heau as Viewed from above, with frontal regions at the top.
Concordance and discordance are mapped separately but on the same colorgraphic scale, where black is intense cordance (either concordance or discordance); there are intermediate levels of cordance, and white is a value of zero (neither concordance or discordance, but a no cordance state).
SUBSTJUTE SHEET
IPEAIUS
I 16 Rec'd PCT/PTO 0 1 MAK '199 PCT/US 92/06789 12 Figures 26A and 26B are alpha concordance and discordance maps for the two DAT subjects on the I reminiscence and hypermnesia paradigm (RK and DL).
Subjects are identified on the left side, along with the ratio of correctly recalled/not recalled items on the reminiscence paradigm (the CC/NN ratio). The higher the ratio, the better the performance. The maps from the CC and NN condition for each subject are displayed separately, with concordance maps in the left column and discordance maps in the right column. Each map repirsents the head as viewed from above, with frontal regions at the top. Concordance and discordance are S mapped separately but on the same colorgraphic scale, where black is intense cordance (either concordance or' discordance), there are intermediate levels of cordance, and white is a value of zero (neither concordance or discordance, but a no cordance state).
Figures 27A, 27B and 27C are a series of maps for a subject in the resting state during 20 seconds of continuous right-hand movement and during seconds of continuous left-hand movement The variable mapped is theta concordance, with darker colors showing more intense concordance. The resting state shows a slight hypofrontal pattern, while both hand movement conditions show frontal activation. Right-hand movement shows preferential activation over the left hemisphere, while left hand movement shows preferential activation over the right hemisphere. All maps show the head as viewed from above.
Figure 28 shows the agreement between alpha concordance and SPECT in assessing normal regional perfusion. Twenty-seven subjects were studied with both SPECT and cordance. Each subject had a brain disease known to affect regional perfusion. The brain was C© divided into six regions (frontal, temporal, and SUBS ITUTE SHEET
IPEA/US
L 4 R H r irim I"A SCT/US 92/06789 12/A occipital, bilaterally) and the proportion of subjects in each brain region who had normal perfusion and alpha concordance were counted. In all but two regions, there Mr.
SUBSTITUTE SHEET
IPEA/US
WO 93/03670 PCT/US92/06789 13 was a high level of agreement between the two measures in defining normal perfusion.
DESCRIPTION
Determining the electrical output of the brain region of a subject and hence the assessment or diagnosis of a disorder or affliction of the brain as characterized by a lesion comprises obtaining first data representative of the energy intensity in the brain region in a primary frequency domain. These data are represented by the absolute power in the primary frequency domain which is defined by specific frequency bands. These are the conventional four frequency bands, namely, delta, theta, alpha, and beta frequency bands of electrical activity.
From these first data, there are determined second data, namely, the relative power, which is representative of energy in a selected primary frequency domain relative to the energy in a secondary frequency domain.
While the primary frequency domain is any one of the frequency bands delta, theta, alpha and beta, the secondary frequency domain can comprise one or more than i one frequency band.
In some cases, the primary frequency domain is several of the frequency bands and the secondary frequency domain is a different frequency band or set of bands which should preferably incorporate at least part of the frequency band or bands of the primary frequency domain.
The absolute power and relative power are related to obtain a representative value of the electrical output in the brain region. Relating is WO 93/03670 PCT/US92/06789 14 effected by determining the absolute power and relative power compared to a selected base value. When the first data and the second data both increase or decrease relative to a selected base value, a concordance condition is indicated. When one of the first data and the second data respectively increase or decrease relative to the selected base while the other of the first data or second data respectively is oppositely directed relative to the 10 selected base, a discordance condition is indicated.
i0 The relationship of the absolute power and relative power is then established. When the absolute power and relative power are both greater than a selected hase value, then a quantified concordance value is calculated, indicated and displayed. Similarly, when one of the absolute powers and relative powers are oppositely directed relative to the selected base value, then a quantified discordance value is calculated, indicated and displayed.
The indicated and displayed values provide the indices of concordance and discordance that are related to the presence of brain lesions. The distribution of concordance and discordance values in the brain region is displayed topographically through cordance mapping.
Thereby, there is obtained a spatial distribution and information relating to the pathophysiological nature of the brain lesions. Through this technique, the evaluation of disorders and afflictions characterized by lesions can be assessed to assist in a diagnosis.
Typical of the diseases and disorders that can be determined are dementing illnesses sich as multi-infarct delentia, Alzheimer's disease and Pick's disease, demyelinating diseases such as multiple sclerosis, as well as lesions among otherwise healthy control subjects.
II
WO 93/03670 PCI/US92/06789 The delta frequency band is conventionally the slowest frequency, being from about 0 Hz to 4 Hz; theta is from about 4 Hz to 8 Hz; alpha is from about 8 Hz to 12 Hz; and beta is from about 12 Hz and higher, namely, to about 20 Hz or 30 Hz in frequency.
In the exemplified version of the invention, the primary frequency domain incorporates any one of these bands. The selected secondary frequency domain includes all of the delta, theta, alpha and beta frequency bands.
The first data are the absolute power. It is indicated in microvolts squared and indicates the energy intensity in a selected single frequency band (primary frequency domain"). The second data are relative power.
It is representative of the energy in a selected single frequency band relative to all the frequency bands ("secondary frequency domain"). The relative power represents a fraction of, or the percentage of, power in the selected single frequency band relative to the absolute power in all frequency bands.
In the determination of the electrical output of a brain region of the head of the subject, an objective base value is first established for each subject. This objective base is conveniently a selected base being a midpoint for the absolute power and a selected base being a midpoint for the relative power for each subject. It is a midpoint of a normalized base value of 1 which is representative of the respective maximum absolute power and the maximum relative power.
The maximum absolute power and maximum relative power are selected values of the first data and the second data, respectively. Values other than the maximum can be selected as necessary.
p.- WO 93/03670 PCT/US92/06789 16 As indicated in Figure 9, the energy distribution is sensed and measured by electrodes located on the head of a patient to obtain analog signals in each electrode for an EEG unit. Each pair of recording electrodes establishes a channel. The analog signal provides a conventional EEG waveform record as indicated.
The analog signal is digitized by the A/D converter in a microcomputer to become digital data. A Fast Fourier Transform (FFT) process is applied to the digital data to yield absolute power values for respective EEG channelsz The relative power also is calculated. These channels represent each of about 20 electrodes located strategically about the head of a patient. The absolute power values and the relative power values each serve independently to provide conventional EEG brain maps as indicated. Such brain maps would otherwise be termed as quantitative EEGs.
With reference to the objective base value which is established for each subject, the maximum absolute power and the maximum relative power is set up for the values across all channels for each frequency band.
The absolute power data and the relative power data are used in combination in accordance with the invention to establish representative values to permit cordance mapping. The absolute power value serves as a basis for determining concordance and discordance calculations which characterize the quantity and quality of the electrical output of the brain region. This is taken in the context of energy from recording locations of all electrode channels and in all the frequency bands.
The absolute power values are processed by computer means into relative power values by dividing, for each channel, the amount of power present in a given r i WO 93/03670 PC/US92/06789 17 frequency band by the total power for each channel.
Relative power thus reflects the distribution of the energy for a channel among the different frequency bands.
There can thus be an absolute power value and a relative power value for each frequency band for each of the electrodes located about the head.
The absolute power and relative power values are normalized by division by the maximum absolute and maximum relative power values, respectively, across all channels and each of the four frequency bands. The maximum absolute power value and thR maximum relative power values are determined by examining the absolute and relative power values for each channel, and selecting the greatest absolute power value and greatest relative power value. These normalized ratios or values are called respectively the "aratio" and 'rratio" and are compared with the maximum values normalized to 1.0 ("normalized base"). This comparison yields the concordance and discordance quantification. These procedures are effected by appropriate computing and microprocessing means programmed to effect the requisite data calculations and processing.
A channel exhibits a discordant pattern and is quantified with a discordance value when the absolute power is diminished relative to its selected base value while the relative power is increased in relation to its selected base value. A selected base value is specifically defined as a percentage, fraction, or proportion of the normalized value 1 ("normalized base"). In a discordant condition, the aratio is less than "1/2 of the maximum absolute power" ("selected base") and the rratio is greater than "1/2 of the maximum relative power" ("selected base").
4! WO 93/03670 PCT/US92/06789 18 In this sense, the normalized value is a "normalized" base, and the midpoint or half point of the base is a "selected base" or proportionate value representative of that normalized base value- The quantified discordance value or score is determined by the sum of the deviation of the absolute power from "1/2 of its base value" ("selected base") and the deviation of the relative value from "1/2 of its base value" ("selected base"), as can be expressed by the form: discordance score (rratio 0.5) (0.5 aratio) A large discordance score describes the condition of a channel with a low power signal that is confined mostly to a given frequency band.
Should the absolute power and relative power j both be increased, the aratio and rratio are both greater than 1/2 maximum, namely, "1/2 of its base value" ("selected base"). Such a channel is considered to show a concordant pattern. The concordance quantification score is then equal to the cumulative elevation above the 1/2 power level for the two normalized values, as can be expressed by the form: concordance score (rratio 0.5) (aratio A large concordance score describes the condition of a channel with a high power signal that is confined mostly to a given frequency band.
The concordance and discordance values can be expressed in terms of a mathematical derivation. This derivation is set out as follows: Let ach,f absolute power in channel ch at frequency band f. Typically, ch is in-the range 1 to 20 in 20 channels of EEG data, and f represents the frequency bands delta, theta, alpha, beta WO 93/03670 PPUS92/067999 Then rch,f relative power in channel ch at frequency band f ach,f all bands ach,i Define a x f maximum absolute power in frequency band f, of all channels rax f maximum relative power in frequency band f, of all channels.
Normalized values of "aratio" and "rratio" are formulated: aratiochf rratiohf ch, f a f arax f rch,f max f These normalized values are then compared with a threshold level, half-maximal values, the selected base value: If (aratioch,f 0.5) and (rratioch,f 0.5) then channel ch is termed "discordant" in frequency band f; If (aratioh,f 0.5) and (rratioch,f 0.5) then channel ch is termed "concordant" in frequency band f.
i i WO 93/03670 PCT/US92/06789 For concordance or discordance, the magnitude of the quantification score can be calculated by the formula: score rratio 0.5 aratio where j denotes the absolute value, and 0.5 represents the normalized 1/2 maximum value.
A typical calculation of quantified values is set out: Discordant Site aratio 0.3 rratio 0.7 aratio 0.5 and rratio so discordance value 0.2 0.2 0.4 Concordant Site aratio 0.7 rratio 0.8 aratio and rratio so concordance value 0.2 0.3 In some situations, it is productive to consider a "selected base" level other than 1/2 the maximum power values. For example, if a recording is notable for a single channel with much higher power than the others, this atypically high value skews the basis of a comparison scale. Such a value would be discarded as an atypical value or outlier.
(f A threshold of 40% or 30% of the normalized maximum of 1 could yield more useful sets of discordance and concordance comparisons in different situations.
Similarly, situations co'ld arise where the threshold level is set at 60% or J t' the normalized maximum.
Such 40%, 30%, 60% or 70,, v. ues would be the "selec--d base." WO 93/03670 PCT/US92/06789 21 With the quantitative EEG results, the cordance mapping is topographically illustrated in a primary frequency domain in Figures 1A, 2A, 3A, 4B, 5B, 6C, 6D, 7B and 8B, respectively, and also Figures 13A, 14A, 16B, 17B, 18C, 18D, 19B and 20B. Each respective domain is illustrated as the delta, theta, alpha or beta ranges in each of the respective Figures 1A, 2A, 3A, 4B, 5B, 6C, 6D, 7B and 8B, and Figures 13A, 14A, 15A, 16B, 17B, 18C, 18D, 19B and 20B, respectively, as indicated.
The most informative cordance map for detecting lesions is usually in the theta or beta frequency bands.
Such mapping is illustrated in Figures 13A, 14A, 16B, 17B, 18C, 18D, 19B and 20B. The data are obtained from the 20 electrodes connected to the EEG unit which measure the electrical activity in the head.
Information is obtained that may indicate the disconnection of cerebral cortex from the fibers that connect brain regions one to another. This may be the common denominator in Alzheimer's disease, Pick's disease, multi-infarct dementia and multiple sclerosis.
In these diseases, gradual severing of the connections that link different brain areas eventually may cause the symptoms of mental ard neurological disability. The representative values as given by the discordance and concordance representative values in the cordance maps of Figures 1 to 8 and Figures 13 to 20 as a determination of the electrical output of these regions of the brain provides useful interpretive data to enable the evaluation of the diseases.
The results for the brain region depicted in Figures 1 through 8 and Figures 13 to 20 were obtained from measuring EEG data on subjects in a supine position with eyes closed. Electrodes were applied in the standard 20 locations on the head. At least 30 seconds I m m 1 11~1 WO 93/03670 PCT/US92/06789 22 of relatively artifact free EEG zeasurements of distribution were effected. The electrodes were applied using standard clinical procedures and the data obtained were stored on an EEG unit.
In this example as illustrated, the EEG unit employed was a system known as QSI 9000 produced by Quantified Signal Imaging, Inc. of Toronto, Ontario, Canada. This system provides data relating to conventional qEEG information, topographical mapping of four frequency bands in the central, frontal, temporal, parietal, and occipital brain regions. Absolute power and relative power data for the different frequency domains are obtained from the EEG measurements.
The avoidance of inaccurate data readings from electrodes about the head can be avoided by using different relationships between any number of selected electrode channels. Computing vector relationships between selected electrodes avoids the effect of referential monopolar values relative to reference electrodes set up in adjacency with the ears of a subject. As such, it has been common in EEG determinations to use monopolar referencing by having a linked ears reference electrode: this means by having electrodes in adjacency to each ear relatively linked. Use of referential monopolar data for the purpose of calculating concordance and discordance creates inaccuracies in cordance calculations having to do with interelectrode distances. While relative power calculations are unaffected by the montages selected, absolute power changes are in pruportion to the square of the interelectrode distance. Thus, the frontal and occipital power estimates are inflated, since these are the furthest points from the reference electrodes. Temporal power is underestimated since this region is closest to the reference electrodes.
4-- WO 93/03670 PCT/US92/06789 23 A configuration is described with reference to Figure 9 to eliminate this problem. Absolute power data collected from the linked ears reference montages are Sfirst reformatted. This is effected using vector calculations set up in a grid of bipolar electrode data, comprising equally-spaced pairs of longitudinal and transverse electrode chains. Power for each individual electrode is then recalculated by averaging power for all respective pairs of electrodes in the chain longitudinally and transversely. Each pair of electrodes in the chain is regarded as a bipolar pair. The concordance and discordance for each individual electrode may be calculated from the data from the bipolar pairs either before averaging, or from the individual electrodes after averaging. The data are then employed to establish the maximum, midpoint and other values as necessary.
As an example with reference to Figure 9, the electrodes 11, 12, 13, 14 and 15 are set out in the first line, 16, 17, 18, 19 and 20 in a second line, and 21, 22, 23, 24 and 25 in a third line. The ears 26 and 27 are indicated relative to nose 28. In a l.nked ear montage, each of the electrodes 11 to 25 is referenced to the ears 26 and 27 which are "electrically" linked as a reference.
The grid of bipolar electrodes is established along the line defined by electrodes 11 to 15, 16 to 20, and 21 to The vertical grid is 11, 16 and 21; 12, 17 and 22, for example. The bipolar data are set up by measuring the data from each electrode in relation to the adjacent electrodes. As such, for example, the power is measured for electrode 18 relative to electrodes 17, 13, 19 and 23. This is repeated for each electrode relative to its adjacent vertical and transverse electrodes. By computer calculation, the calculations are effected to obtain a measure of electrical activity at each electrode and have a power estimate in the region of the brain. This I WO 93/03670 PCr/US92/06789 WO 93/03670 PCT/US92/06789 24 bipolar electrode montage avoids artifacts caused by the linked ear montage.
This reformatting method effectively standardizes electrode distances and may yield information about longitudinally-oriented and transversely-oriented recording vectors. It is sometimes helpful to map concordance and discordance for differently oriented generators (or fiber tracts) on separate maps. In other circumstances, it is helpful to calculate concordance and j discordance after the bipolar data have already been recalculated back to the monopolar format.
The electrode head box which is positioned near the subject contains 20 channels of optically isolated amplifiers. When the patient is prepared, a keyboard command records data from all 20 analog channels. EEG information is then selected for Fast Fourier Transform calculation. Power and spectral amplitudes are calculated for absolute power and relative power and the results of the Fast Fourier Transform are set out in a tabular value of absolute power and relative power.
After analyzing the EEG using the Fast Fourier 2- Transform, the operator generates a topographic map of absolute power, relative power and a cordance map for each of the four conventional EEG frequency bands, namely, the selected primary frequency domain. The data can be stored or displayed on screens or hard copy in a conventional manner.
As illustrated in the flow diagram of Figure 9, the conventional qEEG maps are obtained from the absolute power and relative power values. The absolute power is optionally subjected to the process for standardizing the electrode distances by the bipolar montage. Thereafter, the absolute power is normalized to establish the maximum t WO 93/03670 PCT/US92/06789" absolute power value, namely, the aratio. The midpoint value is established and thereafter, calculations of departures upwardly or downwardly from. the midpoint value Aj are determined. The relative power value is normalized i by establishing the maximum relative power value, namely, the rratio. The midpoint value is established and thereafter, relative power values upwardly or downwardly departing from the midpoint value are established. From this data, respective discordance maps can be obtained in selected frequency bands or concordance maps obtained in selected frequency bands. The discordance map and concordance map can be merged into a cordance map as indicated.
In Figure 10, there is illustrated a sample EEG unit. The electrode head box is shown connected with the head of the patient whereby power measurements can be taken from the brain of the patient. These are fed to the preamplifier and from such an amplifier, conventional EEG data would be recorded. This would constitute a conventional EEG unit. Specialized within that construction are the elements for a qEEG unit. Data from the preamplifier would be directed to the analog to digital converter and, in turn, to a microprocessor. The processor is operated by a keyboard console and the output can be directed to a video display, storage or printer unit.
The microprocessor would operate in terms of the invention to generate the appropriate standardized values, normalization, selected base values, departures from the selected base values, discordance and concordance calculations as indicated in Figure 9.
Figures 11 and 12 are illustrative of the different cordance maps obtained for the same patient in respectively the bipolar montage and the linked ear montage. Illustrated in Figures 11A, 11B, 12A and 12B, respectively, are the absolute power and relative power WO 93/03670 PCT/US92/06789 26 in each of the four frequency bands, theta, delta, alpha and beta. In Figures 11C and 12C, there are discordance maps in four frequency bands and in Figures 11D and 12D, there are concordance maps in four frequency bands.
I V An exemplary data Table I for patient JL is set i out below. Table I includes the data for the frequency ii bands delta, theta, alpha and beta in a bipolar montage.
In each such band, there is set out the absolute power, 1 0 relative power and respective discordance or concordance value. Readings from electrodes of an EEG unit have been taken. These discordance and concordance values are topographically depicted as cordance maps illustrated in Figure 11.
i i TAflE I DEL IA REOUEICY BANDO Absolute Relative Dis- Power Power cordance Concordance IIIEIA FRICUEIICY DA110 Absolute Rlatlve Ols- Power Power cordzance Concordalce AIIIIA rREOWIEIICT BRDI bsolute Relative Die- Conl- Power Power cordance cordarice Absolute Re Power P BETA [REOJEIICL IAIID lotive Dis- Conower cordance cordance 45.300 40.300 20.925 40.225 44.560 50.100 56.700 57.175 70.133 72 .Aoo 69.767 64.800 54.250 64.250 106.630 103.667 3Y 00 53.625 76.000 53.6 50.0 45.3 54.2 40.4 51.9 45.9 51.1 40.9 45.0 49.6 55.0 37.4 56.2 51.2 59.0 49.2 40.1 43.5 22.000 21.030 21.725 22.075 20.000 20.267 33.975 20.275 49.433 20.033 50.067 20.067 59.700 34.075 77.060 50.233 27.000 47.750 65.650 27.0 25.5 34.0 29.7 31.3 20.9 27.5 25.3 34.3 17.4 35.6 23.0 41.1 29.0 37.2 29.0 37.2 35.7 37.2 6.000 4.500 6.350 5.025 0.350 f.900 16.4,50 7.375 12.500 6.1.33 12.067 5.3f00 16.700 0.650 15.260 12.500 5.100 14.000 16.500 90.5 10.400 B.375 6.B25 6.950 10.300 21.467 16.275 19.050 11.333 54.100 8.067 10.727 14.530 7.300 9.400 7.060 4.700 10.500 17.400 12.3 10.2 10.7 9.4 11.2 22.1 13.2 17.0 7.9 33.6 5.7 15.9 10.0 6.4 4.1 13.8 9.9 100.0 20.7 22.2 62.3 69.0 SUBJECI JL REFORHATIED DIPOLAR DATA CcIPUIA1IOIIS DELTA, TIIETA, ALPHA AlNo BETA BAtIOS ABSOIITIE POIIER, RELATIVE POWlER, DISCODOAIICe SCORE, COIICORDAIICE SCORE COROAIICE SCORES LESS 111A)l 10 ARE IIITIED j ;_lli II WO 93/03670 PCT/US92/06789 In a revised form of the computer program implementing the cordance mapping, the data would be represented in Table II for patient JL as set out below.
The data from Table II corresponds to the cordance mapping of Figure 21.
Table II gives relatively better informative data about the subject JL.
1 TAl1.1 I I nEI1rA FRIaOEINCY BAND THT'RmA PI Q ENCY IJAND A LPHA FRIEQUENCY BAND BE TA FREQUENCY BAND AljuIu c Relative Diacor- Concor- Absoliel Relative Discor- Concor- AbsolIte Relative Discor- Concor- Absolute Relative Discor- Concor- Power Power dance dance Power Power dance dance Power Power dance dance Power Power dance dance FI -15.-1 53.6 51.8 0 22.8 27.0 36.3 0 6.0 7.1 25.7 0 10.4 12.3 0 0 12 48.3 56 8 54.7 0 21.1 24.8 33.2 0 4.5 5.3 0 0 11.2 13.1 0 0 J3 28.2 4 1.7 51.2 0 21.7 55.9 0 6.3 10.1 419.5 0 6.8 10.8 0 0 1-I .10.1 51 2 57.6 0 221 29.8 -1-1.0 0 5.0 6.8 28.8 0 6.9 9.3 0 0 1F7 446 48.5 43.5 0 28.8 31.3 39.2 0 8.3 9.0 28.8 0 10.3 11.2 0 0 F8 50.4 51 9 -11.1 0 20.3 20.9 24.8 0 5.1 0 0 21.5 22.1 26.1 0 C3 56.7 39.6 0 0 54.0 37.6 0 60.9 16.3 11.4 0 97.0 16.3 11.4 0 0 C4 57.2 51.1 0 0 28.3 25.3 25.2 0 7.3 6.6 13.1 0 19.0 17.0 14.8 0 T3 70.2 48-1.9 0 51.9 49 4 34.5 0 47.3 12.5 8.7 0 50.5 11.3 7.9 0 0 14 71.1 -46 5 0 48.4 280 18.3 0 0 6.4 4.2 0 0 47.4 31.0 0 100.0 69 8 49.6 0 52.7 50 0 35.5 0 50.7 12.9 9.1 0 56.6 8.1 5.7 0 0 16 64.8 54.9 0 57.3 28.1 23.7 21.7 0 6.3 5.3 0 0 19.0 16.1 11.8 0 P3 54.3 37.4 0 0 59.7 4 1 1 0 76.7 16.7 11.5 0 100.0 14.5 10.0 0 0 1-4 64.2 56.2 0 59.2 34.1 29 8 28.8 0 8.7 7.6 0 0 7.3 6.4 0 0 01 106.7 51.0 0 89.7 77.8 37.2 0 90.5 15.3 7.3 0 541.9 9.4 4.5 0 0 02 103.7 53.5 0 91.4 70.2 36.2 0 78.3 12.5 6.5 0 0 7.3 3.8 0 0 FZ 34 0 48 0 526 0 270 38.1 58.0 0 5.1 7.2 32.2 0 4.7 6.6 0 0 C 53 8 40.2 0 0 47.7 35.6 0 48.0 13 .8 10.3 0 71.8 18.6 13.9 0 0 1Z 76.8 43.6 0 48.7 65.6 37.2 0 74.9 16.5 9.4 0 80.4 17.4 9.9 0 0 Ir
S-;
WO 93/03670 PCT/US92/06789 An interpretation of the electric output in the brain region and diagnosis is set out for Figures 1 through 8.
.1 In Figure 1, the brain imaging studies are for subject JL, a 67 year-old male with multi-infarct dementia. The cordance brain maps (Figure 1A) show discordance in the delta and theta bands. In the preferred forms in Figure 13A, discordance is in the beta and theta bands. The MRI scan (Figure IB) is a T2weighted image showing three discrete white-matter lesions separated from the ventricles, that correspond with the areas of discordance (highlighted with arrows).
The SPECT scan (Figure IC) shows three prominent areas of hypoperfusion that also correspond with the areas of discordance (highlighted with arrows). Absolute power mapping and relative power mapping, which are shown in Figures 12A and 12B respectively do not provide this information. Brain maps represent the head as viewed from above, while MRI and SPECT scans represent the head as viewed from below.
The discordance as illustrated in Figure 1A is closely associated with the presence of deep white-matter ischemic lesions detected by MRI. The decreased absolute slow wave power and increased relative slow wave power seen in the electrodes overlying deep white-matter lesions is demonstrated graphically in Figure IA. The discordance map of Figure IA shows an intense area of discordance in the delta band in the right frontal Sregion. In the preferred form in Figure 13A, discordance is in the beta band in the right frontal region. Three areas of discordance also are seen in the theta band with the largest and most intense focus present in the right frontal region. These areas of discordance coincide closely with three deep white-matter ischemic lesions seen on a T2-weighted MRI scan. In the MRI images, right 4.
WO 93/03670 PCT/US92/06789 31 and left are reversed compared to brain maps. The single largest deep white-matter lesion seen on MRI (right frontal region) corresponds to the largest and most j intense area of discordance, seen in both the delta and theta bands (Figure 1A) or beta and theta bands j (Figure 13A). The ischemic nature of these lesions is confirmed by the subject's SPECT scan, which shows areas of diminished perfusion in the right and left frontal and right posterior head regions over the deep white-matter lesions (Figure IC; same right-left orientation as MRI).
More associations may be determined from the brain cordance map.
In Figure 2, there are additional brain imaging studies for subject JL. The cordance brain map (Figure 2A) shows an intense area of concordance in the delta band in the right posterior head region. In the preferred forms in Figure 14A, there is shown concordance in the theta band in the right posterior head region. The MRI scan (Figure 2B) is a Tl-weighted image showing focal atrophy and ex vacuo ventricular enlargement in the right posterior head region, suggesting an infarction involving the cerebral cortex and corresponding with the area of concordance (highlighted with arrow). The SPECT scan (Figure 2C) shows a prominent area of hypoperfusion that also corresponds with the are&. of concordance (high-lighted with arrow). Absolute power mapping and relative power mapping, which are shown in Figures 12A and 12B respectively do not provide this information. Brain maps Srepresent the head as viewed from above, while MRI and SPECT scans represent the head as viewed from below.
Concordance is associated with several conditions including infarctions with cortical involvement.
Interestingly, SPECT scanning may have difficulty distinguishing between ischemia that is due to deep WO 93/03670 PCT/US92/06789 32 white-matter ischemic lesions or to infarction with cortical involvement. Cordance mapping yields additional valuable diagnostic information about the nature of these lesions.
Accordingly, discordance is associated with deep white-matter lesions and concordance is associated with infarction with cortical involvement.
In Figure 3, there are the brain imaging studies for subject RC, a 67 year-old female with dementia of unknown etiology. The cordance brain map (Figure 3A) shows a broad area of intense discordance in the delta band in the left posterior head region. In the preferred form in Figure 15A, there is intense ji discordance in the beta band. The first MRI image (Figure 3B) is a T2-weighted axial view showing a large patch of presumed deep white-matter ischemic disease in the left posterior head region adjacent to the ventricular horn, that corresponds with the intense discordance (highlighted with arrow). A second MRI image (Figure 3C) shows multiple punctate areas of presumed ischemic disease that also correspond with areas of discordance (highlighted with arrows). Absolute power mapping and relative power mapping do not provide this information. Brain maps represent the head as viewed from above, while MRI scans represent the head as viewed from below.
The sensitivity of the cordance technique to the presence of smaller lesions is demonstrated by the case of subject RC, whose cordance maps are shown in Figure 3A. The less intense area of discordance over the right temporal region coincides with a few scattered punctate ischemic lesions seen deep below the temporal cortex (Figure 3C).
I I c t WO 93/03670 PCT/US92/06789 33 Figure 4 are the scans of GK, an 87 year old male who presented with prominent memory loss and wordfinding difficulties. He was given provisional diagnosis of Alzheimer's disease. A PET scan, Figure 4A, shows prominent biparietal hypometabolism, as well as right frontotemporal hypometabolism (arrows). The discordance map for the same subject (Figure 4B) shows biparietal delta discordance, more prominent on the right, corresponding to the PET pattern. In the preferred form in Figure 16B, there is biparietal beta discordance. In addition, there is a right frontotemporal focus of discordance correlating with the PET scan (arrows). The PET scan shows the brain as viewed from below, while the discordance map shows the brain as viewed from above.
Figure 5 depicts scans of LB, a 51 year old female with a diagnosis of Pick's disease. A SPECT scan (Figure 5A) highly suggests this diagnosis, with prominent and severe frontal hypoperfusion (arrows). The discc,-dance map (Figure 5B) shows intense bilateral frontal discordance (arrow). In the preferred form in Figure 17B, there is intense bilateral frontal theta discordance as well. The SPECT scan is viewed from below, and the discordance scan is viewed from above.
Figure 6 is additional brain imaging studies for subject LB. In Figure 6A, the brain maps of absolute power are shown in the delta, theta, alpha, and beta bands (from top). Figure 6B shows the maps of relative power in the same frequency bands. Both of these columns show a diffuse excess of slow-wave activity that does not have any clear regional predominance. The map in Figure GC is a discordance map of the same subjecti showing clear and prominent frontal discordance in the theta band most prominently, and most significantly affecting the right hemisphere. In the map in Figure 6D, there is a diffuse concordance that is usually bilaterally I cI pI- WO 93/03670 PCT/US92/06789 34 symmetric, and is of no significance in this case. In the preferred form, discordance is shown in Figure 18C and concordance is shown in Figure 18D.
Figure 7 illustrates a scan of SE, a 26 year old white .lle with multiple sclerosis. The MRI scan (Figure 7A) shows a single large demyelinating lesion underlying the left frontotemporal cortex (arrow). The discordance map (Figure 7B) shows a prominent area of discordance in the left frontotemporal region. In the preferred form in Figure 19B, the theta discordance map shows discordance in the left frontal temporal region.
The MRI shows the brain as viewed from below, while the discordance map shows the brain as viewed from above.
Fig':. 8 and 20 show scans for PH, a 76 year old male contr subject with deep white-matter ischemic lesions in the frontal lobes. A RMPAO SPECT scan for the subject (Figure 8A) shows globally diminished cerebral perfusion, with the most striking decreases seen in the frontal lobe (arrows). Figures 8B and 20B (the preferred form) show a theta discordance map for this same subject, with at least mild discordance in most brain regions, and prominent frontal discordance corresponding to the areas of greatly diminished perfusion (arrows). The SPECT scan is viewed from below, while the discordance map is viewed from above.
The cordance mapping is used to assess the presence and nature of brain lesions. The data obtained by the cordance mapping conforms substantially and equivalently to the data obtained by the MRI scan, PET or SPECT scan as illustrated in the figures. The values representative of the combination of the absolute power data and relative power data provide for cordance brain mapping. Such mapping thus provides .a valuable advance.
Absolute power and relative power mapping considered j WO 93/03670 PCF/US92/06789 separately does not provide these data. It is thus possible with the cordance brain mapping technique using the quantitative EEG data to obtain effective information to facilitate evaluation of electrical output of the brain, and hence the presence and nature of disease conditions.
It may be unnecessary to resort to the relatively expensive SPECT and PET techniques. The diseases represented by the information obtained by cordance brain mapping are the result of deep lesions in the brain that produce excessive delta and theta slow wave activity in an EEG. Detection of these lesions by conventional EEGs or currently available methods of qEEGs is not possible. Thus, a conventional qEEG would provide only data about absolute power and about relative power independently. From such unrelated data, it is not possible to obtain the same information as cordance mapping to assist in characterizing the human brain.
The quantified methods increase the sensitivity of the EEG and the cordance mapping extendF this sensitivity to provide useful information. The examination of the cordance map distribution of the absolute power and relative power in the delta and theta bands particularly over the surface of the brain provides useful information. The discordance and concordance values are determined by a calculation of the comparison of the individual electrode absolute and relative power with the maximal absolute and maximal relative power values over the whole brain. A brain region shows a discordant pattern in a given frequency band if the relative power from the corresponding electrode is increased above half the maximum relative power value for the subject while the absolute power is decreased below half the maximumn absolute power value of the subject. Conversely, the brain region shows a concordance pattern where both the 1 II WO 93/03670 PCT/US92/06789 36 absolute power and relative power value from the site areI increased about the half maximal values of that subject.
The sensitivity and specificity of both discordance and concordance may be adjusted by changing the thresholds at which the two measures are defined. By requiring that concordant increases in absolute and relative power be 10%, or 20% above the half-maximal value ("selected base") for that subject, the specificity of the measure may be increased. Similarly, by requiring that discordant absolute and relative power be separated by large differences, the specificity of the discordance measure may be increased. There are other parameters that may be adjusted as well. For example, the halfmaximal value may be calculated in several different ways. It may be based on half-maximal value from all regions for that individual subject, the mean or median value for that subject, or a half-maximal value after the 1 or 2 highest values (which may be outliers) have been eliminated. These further adjustments may change the sensitivity, specificity, or usefulness in different clinical situations.
Cordance mapping has been developed on the population of mostly elderly subjects with possible J organic mental syndromes, as well as young adults with multiple sclerosis. There are a number of other possible applications for this technique among young and older adult populations as well. Possible other applications (j 30 include populations at risk for deep brain tumors, such as patients with a history of brain tumor who are being monitored for possible recurrence, patients with AIDS who are at risk for central nervous system lymphoma, multiple sclerosis, patients with epilepsy, and other brain diseases.
i .A i I- WO 93/03670 PCT/US92/06789 37 Applications of the invention relate to different fields of neurophysiology. The cordance mapping can be continually monitored during medical ."cedures such as surgery or in treatment in intensive ~ae units. Similarly, during treatment of patients changes in the mapping would indicate data relating to the effectiveness of treatment, or improvement or deterioration of subjects. The cordance mapping techniques can be used to determine or assess the brain in accident situations or diseases such as cerebral vascular diseases or strokes which may be the result of genetic or developmental-congenital problems, traumatic head injury, exposure to toxic agents or the product of other pathogenic physiological processes such as elevated blood pressures, stress responses, and arterial blockages.
It should be possible with cordance methods to facilitate diagnosis of epilepsy, substance abuse, genetic disorders, diseases of the kidney or liver affecting brain function, sensitivities relating to food and odor which correlate with behavioral changes, illnesses accompanied by high fevers, viral or bacterial infection, sensory or motor handicaps which would include visual handicaps, auditory and motor handicaps, learning disabilities, psychiatric disorders, headaches, cyclical hormonal reactions, and other dysfunctions.
This invention has application to any disease state that affects the gray- or white- matter of the brain, either at the cortical, subcortical white-matter, or subcortical grey matter level. Therefore, patients with epilepsy who have cortical or subcortical dysianction, patients with inheritable diseases that affect brain function at the cortical or subcortical level, as well as tumors, trauma, or infectious processes that might affect brain function all may be usefully evaluated using cordance mapping.
A
i WO 93/03670 PCT/US92/06789 38 By this invention, there is provided a method, apparatus, and system for obtaining useful assessment and diagnosis of the brain based upon electrical activity.
Assessment Of Activation Tasks Cordance has applications beyond detection of lesions causing cortical deafferentation. Cordance is sensitive to the presence of brain tissue with high or low perfusion in subjects with brain disease. Since cordance is standardized to a midpoint of electrical energy production for an individual, it is possible to detect states of high or low perfusion even within the normal range. Such states of high and low perfusion likely accompany the augmented flow in some brain areas during activation tasks. Concordance and discordance during activation tasks are set out.
The measure of concordance appears to be associated with the activation of specific brain regions involved in mental processing. This is demonstrated using a hand opening and closing task in a normal control subject. The concordance in the alpha band for this subject is shown in Figure 27A, in which there is minimal concordance seen in the frontocentral region. With opening and closing of the right hand, there is a prominent increase in concordance in the frontocentral region on the left, roughly corresponding to the area of the motor strip (Figure 27B). This fiinding is consistent with previous blood flow studies showing increases in flow to this area during motor tasks. With opening and closing of the left hand, a slightly different pattern is seen, with an increase in concordance inr the frontocentral region but more prominently on the right (Figure 27C). The change in laterality corresponds with the physiology of motor control; the less-specific WO 93/03670 PC/US92/6789.
39 pattern on opening and closing of the left hand could reflect the fact that the subject was right handed.
While concordance appears to be associated with the activation, discordance appears to be associated with deactivation. This association is shown by cordance j mapping of the alpha frequency band (8-12 Hz) during the i encoding phase of the visual memory reminiscence and hypermnesia paradigm. Eleven subjects were studied: 1i 0 five were normal elderly controls (CON), four had major SI depressive episodes (MDE), and two suffered from early dementia, probably of the Alzheimer's type (DAT).
i The reminiscence paradigm is discussed below.
Subjects were shown slides of pen-and-ink drawings of easily identified objects, each for a period of five seconds. Quantitative EEG (qEEG) data were collected in synchrony with the presentations, for later identification of the data recorded during each slide presentation. The subjects ware asked to recall as many items as possible three miJnutes after presentation of the stimuli, and then again f~r a four-minute recall test and two inter-test intervals. All the stimuli presented were then scored as to whether they were recalled correctly in both recall periods (a CC rating), only on one occasion (CN or NC rating), or neither (NN rating).
The CC and NN data were analyzed, since these conditions represent the extremes of successful (CC) and unsuccessful (NN) memory encoding.
SAfter both recall periods, a post-hoc analysis was performed and data from all CC and NN recording epochs were pooled to create average cordance maps for the subjects in the CC and NN memory encoding states.
Performance of subjects was rated according to a ratio of the number of items recalled .rrectly on both recall 4I PCT/US 92/06789 attempts divided by the number of items not recalled on either recall attempt (the CC/NN ratio) There was a broad range of performance among subjects in the CON and MDE categories. Three of the r five CON subjects had CC/NN ratios between 1 and 3, with the other two subjects having ratios between 0.5 and 1.
Two of the MDE subjects had CC/NN ratios of approximately 1, a third subject had a ratio between 0.5 and 1, and the 10 fourth a ratio of 0.18. Finally, the two demented Ssubjects had CC/NN ratios between 0.3 and V Two patterns of neurophysiologic activation i were seen in all subjects, that were strongly associated with the degree of success in performance of the memory Stask. The first pattern involved the temporal regions bilaterally (specifically, the T3 and T5 recording electrodes on the left, and the '4 and T6 recording electrodes on the right). A high CC/NN ratio was associated with preferential left temporal concordance in the CC state; for these "good performers," the NN state was readily distinguished by a shift to right temporal concordance in the NN condition. This pattern is evident for the top three performers on the test (subjects EH, LD, and LG, Figures 22A, 22B and 22C). Also evident for the two highest performers (EH and LD) is a pattern of Scentral discordance, or deactivation (specifically involving the Cz electrode). Thus, optimal-performance as characterized by both a preferential left-temporal a 30 activation and a central deactivation in the CC condition.
The two CON subjects who performed more poorly had a different pattern (Figures 23A and 23B). While one of them (subject MG) showed the pattern of left temporal concordance in the CC condition, shifting to right temporal concordance in the NN condition, the subject SU TITUTE SHEET SIfPEAl
US-
L. r-18 Rec'd PCT/PO O~ MA w199 IPCT/US 92/06789 41 also had prominent central concordance in the CC state.
The CON subject who performed most poorly (subject AS) lacked any features of the successful performance pattern; the subject had no left temporal concordance, but had prominent central concordance in the CC condition.
The four depressed subjects, who performed more poorly than the best CON subjects on the reminiscence task, lacked the neurophysiologic characteristics of good test performance, and had features consistent with poor performance (Figures 24A and 24B; and Figures 25A and Subjects CM and AM lacked left temporal concordance seen in optimal CC performance. They did, however, show central discordance, and were able to maintain a CC/NN ratio slightly greater than 1. Subject SC showed left temporal concordance in the CC condition, which was exaggerated compared to that seen among the control subjects. The subject lackeo the pattern of central discordance, however, and had a CC/NN ratio of less than one. Finally, subject LM lacked left temporal concordance in the CC condition, but had prominent central concordance; the subject registered the worst performance of any of the depressed subjects.
Finally, both subjects with dementia, who had uniformly poor performance, showed a prominent pattern of central concordance (Figures 26A and 26B). This pattern was similar to that of subject LM in the depressed group, who had the most profound cognitive impairment on i clinical neuropsychological testing of any of the depressed subjects. Interestingly, subject LM also had prominent deep white-matter ischemic disease, significantly more than any of the other subjects in this sample. After two months of antidepressant treatment, the subject's mood improved significantly.
SSUBSTITUTE SHEET k IPEAUS c. i~ ri WO 93/03670 PCT/US92/06789 42 The consistency of the results shows that there are neurophysiologic differences between successful and unsuccessful memory encoding detected by cordance mapping. There is an association between certain patterns of neurophysiologic activation (concordance) and deactivation (discordance) and good or poor memory task performance.
These data are consistent with the nature of the memory task and with the previous results on the neurophysiology of memory. Optimal encoding appears to depend on both the left and right temporal regions in these subjects, but primarily the left temporal region.
This is consistent with the structure of the paradigm, which involves both encoding of visual stimuli and later verbal written reporting of the stimulus. The data could K be interpreted as showing that left temporal activation is more important than right temporal activation for successful completion of the task, possibly because of a verbal naming and encoding process that occurs contemporaneously with visual memory encoding.
This finding coincides with results that a left/right ratio of alpha power increased during tasks that require greater left hemispheric processing. Three of four depressed subjects lacked the pattern of left temporal activation in the CC condition, and the fourth had an exaggerated response. This observation is i consistent with that dysregulation of left and right hemispheric activation (specifically including the temporal regions) seen in depression.
The pattern of central activation associated with unsuccessful task completion also is consistent with observations in neurophysiology. In the resting state there is a prominent "alpha rhythm" present over the posterior head regions, and with cognitive tasks this F- 4 WO 93/03670 PCT/US92/06789 43 rhythm attenuates. Results show that there is prominent alpha concordance over these regions at rest. Successful engagement in the task may suppress this concordance, just as it does the alpha rhythm. Central alpha concordance may be a marker for failure to engage in a task, and discordance a marker for successful engagement.
Cordance reliably characterizes the perfusion of brain tissue. While in certain frequency bands, concordance is associated with an infarction, in other bands. Concordance is a signal indicating that normallyperfused brain tissue underlies a recording electrode.
Discordance is a signal indicating that hypoperfused brain tissue underlies a recording electrode. Cordance is both a qualitative and quantitative indicator of the nature of brain perfusion. Cordance indicates whether normally-perfused or hypoperfused tissue is present (the qualitative indicator), and also provides information about the mean tissue perfusion and the volume of normally-perfused or hypoperfused tissue (the quantitative indicator).
In particular, there is a strong relationship between mean perfusion and concordance in the alpha frequency range thereby providing a quantitative indicator of perfusion. As illustrated in Figure 28, results of comparative data between SPECT scans and concordance mapping for six different brain regions in 27 subjects show a high level of agreement in four of the brain regions examined.
While alpha concordance is an indicator of normal perfusion, and beta and theta discordance are indicators of hypoperfusion, the no cordance condition in certain frequency bands is an indicator of even lower perfusion.
i 1, WO 93/03670 PCT/US92/06739 44 Many other examples of the invention exist each differing from another in matters of detail only. For instance, although the data have been set out as power, it is possible that other representations of energy can be used. This could be voltage, amplitude, or coherence.
Although each of the first data and second data are defined relative to their own base value, it may be possible to have a common base value.
1 0 Also, whereas the primary frequency domain is i described as essentially a single frequency band of the total relevant spectrum of the four conventional bands from zero to greater than about 12 Hz, the primary frequency domain could be differently defined. It could be more than any one of the four frequency bands. Also, i the secondary frequency domain may be greater or less than any one of the four conventional frequency bands.
Similarly, the time interval evaluation of 4-second periods for measuring data in each of the channels may be different. In different situations, data from a different number of selected electrode channels may be used to generate the appropriate first data and second data in the different frequency domains.
Also, although the concordance has been described with reference to increases in a percentage proportional or fractional value of a base value, it is possible that a concordance value where both first and second data are lower than this base value can be used.
Also, although the system has been described with reference to 20 channels, more or less channels may be used. It is possible, for instance, to increase the number of channels to at least about 128. Indeed, it is possible that the greater the number of channels, the greater the amount of data will be obtained. This should provide for more effective analysis.
p-c8D~exr~C WO 93/03670 PCT/US92/06789 Different techniques can be used to overcome the artifacts caused by linked ear reference montage.
For instance, compensation factors can be ascertained and applied for different power intensities and/or electrode distances in each brain region. This application can be computed into the absolute power determinator to permit establishing the appropriate referential value.
The invention is defined in "he following claims.
Vi ii

Claims (40)

1. A 'ethod of determining the electrical output of a brain region in the head of a subject comprising obtaining first data representative of energy in the brain region in a primary frequency domain, determining second data representative of energy in the primary frequency domain substantially simultaneously relative to the energy in a secondary frequency domain, and relating the first data with the second data thereby obtaining a value representative of electrical output in the brain region.
2. A method of determining the electrical output of a brain region in the head of a subject comprising obtaining first data representative of energy in the brain region in a primary frequency domain, determining second data representative of energy in the primary frequency domain substantially simultaneously relative to the energy in a secondary frequency domain, and relating the first data with the second data thereby obtaining a value representative of electrical output in the bi'ain region, wherein relating is effected by determining the first data and second data relative to a selected base value and wherein when the f'-qt data and the second data both increase or decrease relative to the selected base value, a concordance condition is indicated, and wherein when one of the first data and the second data respectively increase or decrease relative to the selected base while the other of the first data or second data, respectively, is oppositely directed relative to the selected base, a discordance condition is indicated.
3. A method as claimed in claim 2 including providing a selected base for the first data and a selected base for the second data.
4. A method as claimed in claim 2 wherein the first data are compared 2 to a selected base value of the first data and the second data are compared to a selected base value of the second data thereby to obtain respectively either the concordance or discordance indication, and wherein the discordance and concordance is established in the primary frequency domain. A method as claimed in claim 2 including obtaining a quantified value of the amount of departure of the discordance indication and the concordance indication by determining the amount of departure from the selected base. S4/7195JB25161 .NP,46 77 I -ii- ,1 47
6. A method as claimed in claim 5 including mapping topographically the quantified value over the brain region.
7. A method as claimed in claim 5 including having multiple primary frequency domains and including mapping the quantified value for multiple primary frequency domain.
8. A method as claimed in claim 5 including displaying a topographical map of the quantified value in a primary frequency domain.
9. A method as claimed in claim 5 wherein the primary frequency domain includes at least one of a delta region and a theta region.
10. A method as claimed in claim 2 wherein the first data are obtained from energy measured by selected electrode channels, and locating the selected electrode channels strategically about the brain.
11. A method as claimed in claim 2 wherein the first data are an absolute power, and the second data are a relative power, the absolute power being power measured by selected electrode channels over the primary frequency domain and the relative power being the distribution of power in the primary frequency domain relative to the power in the secondary frequency domain in the selected electrode channels.
12. A method as claimed in claim 2 inr-'uding comparing the representative value with a selected base representative of the brain region and assessing from the comparison the physiology in the brain region.
13. A method as claimed in claim 2 including diagnosing from the representative value the existence or non-existence of a brain lesion characterized by at least one of the disorders indicated by dementia, such disorders being selectively multi-infarct dementia, Alzheimer's disease, Pick's disease or a demyelinating disease, selectively, multiple sclerosis. \14. A method as claimed in claim 2 including normalizing the effect of a S selected energy distribution in the brain region, such region being selectively adjacent to at least one of the ears of the subject, the normalizing being effected by determining an energy measurement of different electrodes relative to data of at least one other electrode. 4/7/95JB25161.NP,47 48 A method of determining the electrical output of a brain region in the head of a subject comprising obtaining first data representative of energy in the brain region in a primary frequency domain, determining second data representative of energy in the primary frequency domain substantially simultaneously relative to the energy in a secondary frequency domain, and relating the first data with the second data thereby obtaining a value representative of electrical output in the brain region, wherein the first data are divided by a selected first data value, and the second data are divided by a selected second data value thereby to obtain a normalized base value for normalizing the first data, and a normalized base for normalizing the second data, respectively, and wherein the first data relative to the normalized base value of the first data and the second data relative to the normalized base value of the second data yields concordance and discordance indications.
16. A method as claimed in claim 15 including employing a selected percentage of the normalized base value of the first data as a first selected base value, and employing a selected percentage of the normalized base value of the second data as a second selected base value and wherein when the first data are relatively less than the first selected base value and the second data are relatively greater than the second selected base value, respectively, a discordance is indicated, and wherein when the first selected data is increased relative to the first selected base value and the second data is relatively increased relative to the second selected base value, a concordance is indicated.
17. A method of determining the electrical output of a brain region in the head of a subject comprising obtaining first data representative of energy in the 2. brain region in a primary frequency domain, determining second data representative of energy in the primary frequency domain substantially simultaneously relative to the energy in a secondary frequency domain, and relating the first data with the second data thereby obtaining a value representative of electrical output in the brain region, wherein the first data are an abs :ite power, and the second data are a relative power, the absolute power being power measured by selected electrode channels over the primary frequency domain and the relative power being the 4/7195JB25161.NP,48 I 49 ii distribution of power in the primary frequency domain relative to the power in the B secondary frequency domain in the selected electrode channels.
18. A method as claimed in claim 17 wherein relating the absolute power and the relative power is defined by the combination of the absolute power and relative power such that the relative power at a selected primary frequency domain is equal to the absolute power at the selected primary frequency domain divided by the power for the second frequency domain.
19. A method of determining the electrical output of a brain region in the head of a subject comprising obtaining first data representative of energy in the brain region in a primary frequency domain, determining second data representative of energy in the primary frequency domain substantially simultaneously relative to the energy in a secondary frequency domain, and relating the first data with the second data thereby obtaining a representative value of electrical output in the brain region, including comparing the representative value with a selected base representative of the brain regio! and assessing from the comparison the physiology in the brain region. A method as claimed in claim 19 wherein the first data are obtained from energy measured by selected electrode channels, and locating the selected electrode channels strategically about the brain.
21. A method as claimed in claim 20 wherein multiple channels are obtained by locating multiple electrodes over the head of the subject in strategic locations about the head, obtaining data in an analog form from the electrodes, digitizing the analog data from the electrodes, and subjecting the digitized data to Fourier Transformation to obtain absolute power for each channel in the primary -5 frequency domain.
22. A method as claimed in claim 21 including obtaining a relative power for each channel, such relative power being obtained by dividing the absolute power in the primary frequency domain by the absolute power in the secondary frequency domain. ai 4/7/95J25161.NP,49 a ~d~iiLJ
23. A method as claimed in claim 20 wherein the erergy is measured by the electrode for each channel, the energy measurement being obtained with reference to at least one other electrode located on the subject.
24. A method as claimed in claim 23 wherein the energy measured by the electrodes for each channel is obtained with reference to multiple electrodes about the head. A method of determining the electrical output of a brain region in the head of a subject comprising obtaining first data representative of energy in the brain region in a primary frequency domain, determining second data representative of energy in the primary frequency. domain substantially simultaneously relative to the energy in a secondary frequency domain, and relating the first data with the second data thereby obtaining a representative va ue of electrical output in the brain region, including diagnosing from the representative value the existence or non-existence of a brain lesion characterized by at least one of the disorders indicated by dementia, such disorders being selectively multi-infarct dementia, Alzheimer's disease, Pick's disease or a demyelinating disease, selectively, multiple sclerosis.
26. A method for determining the electrical output of a brain region in the head of a subject comprising obtaining first data representative of energy in the brain region in a primary frequency domain, determining second data representative of energy in the primary frequency domain substantially simultaneously relative to the energy in a second frequency domain, and relating the first data with the second data thereby obtaining a value representative of electrical output in the t "brain region, including normalizing the effect of a selected energy distribution in the brain region, such region being selectively adjacent to at 1:ast one of the ears of Sthe subject, the normalizing being effected by determining an energy measurement of different electrodes relative to data of at least one other electr'.,
27. A method of determining the electrical output of a brain region in the head of a subject comprising obtaining first data representative of energy in Zhe brain region in a primary frequency domain, substantially simultaneously determining second data representative of energy in the primary frequency domain C. Rl4/7/95JB25161 7~E; 0 51 relative to the energy in a secondary frequency domain, relating the first data with the second data thereby obtaining a value representative of electrical output in the brain region, and obtaining a brain map of the representative value.
28. A method of determining the electrical output of a brain region in the head of a subject comprising obtaining first data representative of energy in the brain region in a primary frequency domainr, determining second data representative of energy in the primary frequency domain substantially simultaneously relative to the energy in a secondary frequency domain, and relating the first data with the second data thereby obtaining a representative value of electrical output in the brain region, and obtaining a brain map of the representative value including obtaining a normalized base value for the first data and a normalized base for the second data respectively, obtaining simultaneously selected base values from the normalized base values and obtaining the representative value based on departures from the selected base values.
29. A method of determining the electrical output of a brain region in the head of a subject comprising obtaining first data representative of energy in the brain region in a primary frequency domain, determining second data representative of energy in the primary frequency domain substantially simultaneously relative to the energy in a secondary frequency domain, and relating the first data with the second data thereby obtaining a representative value of electrical output in the brain region, and obtaining a brain map of the representative value including comparing the representative value with a simultaneously obtained selected base representative of the brain region and assessing from the comparison the physiology in the brain region. A method of determining the electrical output of a brain region in the head of a subject comprising obtaining first data representative of energy in the brain region in a primary frequency domain, substantially simultaneo,,i:'y determining second data representative of energy in the primary frequency dom3in relative to the energy in a secondary frequency domain, normalizing the first data, normalizing the second data, selecting a simultaneously obtained base value relative to the respective normalizations, determining departures of the first data 417/95JB25161.NP51 yjI l 0 52 and the second data from the respective selected base values, and relating the departures thereby to obtain a brain map representative of electrical output in the brain region.
31. A method oi Ik nining the electrical outpijt of a brain region in the i 5 head of a subject compri. ining first data representative of energy in the brain region in a primary frequelcy domain, determining second data representative of energy in the primary frequency domain substantially simultaneously relative to the energy in a secondary frequency domain, normalizing the first data, normalizing the second data, selecting a base value relative to the respective normalizations, determining departures of the first data and the second data from the respective selected base values, and relating the departures thereby to obtain a brain map I representative of electrical output in the brain region, including having multiple primary frequency domains and including effecting mapping for the multiple primary frequency domains.
32. A method as claimed in claim 31 including displaying a topographical map of the representative values in a primary frequency domain.
33. A method of determining the electrical output of a brain region in the head of a subject comprising measuring an absolute power in the brain region in a primary frequency domain, substantially simultaneously determining a relative power in the primary frequency domain relative to the absolute power in a secondary frequency domain, normalizing the absolute power, normalizing the relative power, selecting a simultaneously obtained base value relative to the respective normalizations, determining departures of the absolute power and the relative power from the respective selected base values, and relating the departures t hereby to obtain a cordance brain map representative of electrical output in the brain region.
34. A method of determining the electrical output of a brain region in the head of a subject comprising measuring an absolute power in the brain region in a primary frequency domain, determining a relative power in the primary frequency domain relative to the absolute power in a secondary frequency domain, normalizing the absolute power, normalizing the relative power, selecting a base 4/7/95JB251 61 .NP,52 4I 53 value re!ative to the respective normalizations, determining departures of the absolute power and the relative power from the respective selected base values, and relating the departures thereby to obtain a cordance brain map representative of electrical output in the brain region, including obtaining a topographical map of the representative values in a primary frequency domain. A method as claimed in claim.34 wherein the primary frequency domain includes one of a delta region and a theta region, and the secondary frequency domain is selectively at least both of the delta and theta regions.
36. A method as claimed in claim 35 wherein the absolute power is obtained from selected electrode channels, and locating the selected electrode channels strategically about the brain.
37. Apparatus for determining the electrical output of a brain region in the head of a subject comprising means for obtaining Irst data representative of an energy in the brain region in a primary frequency domain, means for determining 1 R substantially simultaneously second data representative of energy in the primary frequency domain relative to the energy in a secondary frequency domain, and means for relating the first data with the second data thereby obtaining a value representative of electrical output in the brain region.
38. Apparatus as claimed in claim 37 including means for comparing the first data to a simultaneously obtained selected base value of the first data and means for comparing the second data to a simultaneously obtained selected base value of the second data. S39. Apparatus as claimed in claim 37 including electrode channels for location about the head and wherein the first data are absolute power, and the second data are relative power, the absolute power being power from a selected electrode channel over the primary frequency domain and the relative power being the distribution of power in the primary frequency relative to a secondary frequency domain in the selected electrode channel. Apparatus as claimed in claim 39 including means for measuring the energy by the electrode for each channel, and means for obtaining the energy measurement with reference to at least one other electrode about the subject. 4/7195JB25161.NP,53 54
41. Apparatus for determining the electrical output of a brain region in the head of a subject comprising means for obtaining first data representative of an energy in the brain region in a primary frequency domain, means for determining second data representative of energy in the primary frequency domain substantially simultaneously relative to the energy in a secondary frequency domain, and means for relating the first data with the second data thereby obtaining a value representative of electrical output in the brain region, including means for determining a selected base value, the value being selectively normalized, means for relating the first data and second data relative to the selected base value, and means for determining selectively concordance and discordance conditions of the first data and second data relative to the selected base value.
42. Apparatus as claimed in claim 41 including means for determining a selected base value for the first data and a selected base value for the second data.
43. Apparatus as claimed in claim 41 including means for comparing the first data to a selected base value of the first data and means for comparing the second data to a selected base value of the second data.
44. Apparatus as claimed in claim 43 including means for quantifying an amount of a departure of the first data from a selected base value and the amount of departure of the second data from a selected base value.
45. Apparatus as claimed in claim 44 including means for mapping the quantified value over the brain region.
46. Apparatus as claimed in claim 44 including means for selecting multiple primary frequency domains and including means formapping the quantified value for multiple primary frequency domains. 2 5 47. Apparatus as claimed in claim 44 including means for displaying a topographical map of the quantified value in a primary frequency domain.
48. Apparatus as claimed in claim 41 including electrode channels for location about the head and wherein the first data are absolute power, and the second data are relative power, the absolute power, and the second data are relative power, the absolute power being power from a selected electrode channel over the primary frequency domain and the relative power being the distribution of 4/7/95J825161.NP,54 I power in the primary frequency relative to a secondary frequency domain in the j -ted electrode channel. S49. Apparatus for determining the electrical output of a brain region in the head of a subject comprising means for obtaining first data representative of an energy in the brain region in a primary frequency domain, means for determining second data representative of energy in the primary frequency domain substantially simultaneously relative to the energy in d secondary frequency domain, and means for relating the first data with the second data thereby obtaining a value representative of electrical output in the brain region including means for comparing the first data to a selected base value of the first data and means for comparing the second data to a selected base value of the second data, including means for quantifying an amount of a departure of the first data from a selected base value and the amount of departure of the second data from a selected base value. Apparatus as claimed in claim 49 including means for mapping the 'I quantified value over the brain region.
51. Apparatus as claimed in claim 49 including means for selecting multiplo primary frequency domains and including means for mapping the quantified value for multiple primary frequency domains.
52. Apparatus as claimed in claim 49 including means for displaying a topographical map of the quantified value in a primary frequency domain. DATED this 4th day of July, 1995. THE REGENTS OF THE UNIVERSITY OF CALIFORNIA "2 By their Patent Attorneys: CALLINAN LAWRIE t:1 4/7/95J8251 61
AU25161/92A 1991-08-16 1992-08-12 Determining brain activity including the nature of brain lesions by electroencephalography Ceased AU662760B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US745872 1991-08-16
US07/745,872 US5269315A (en) 1991-08-16 1991-08-16 Determining the nature of brain lesions by electroencephalography
PCT/US1992/006789 WO1993003670A1 (en) 1991-08-16 1992-08-12 Determining brain activity including the nature of brain lesions by electroencephalography

Publications (2)

Publication Number Publication Date
AU2516192A AU2516192A (en) 1993-03-16
AU662760B2 true AU662760B2 (en) 1995-09-14

Family

ID=24998593

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25161/92A Ceased AU662760B2 (en) 1991-08-16 1992-08-12 Determining brain activity including the nature of brain lesions by electroencephalography

Country Status (6)

Country Link
US (2) US5269315A (en)
EP (1) EP0641175A1 (en)
JP (1) JPH06509730A (en)
AU (1) AU662760B2 (en)
CA (1) CA2115650A1 (en)
WO (1) WO1993003670A1 (en)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5450855A (en) * 1992-05-13 1995-09-19 Rosenfeld; J. Peter Method and system for modification of condition with neural biofeedback using left-right brain wave asymmetry
US5445162A (en) * 1993-08-27 1995-08-29 Beth Israel Hospital Association Apparatus and method for recording an electroencephalogram during magnetic resonance imaging
USRE36450E (en) * 1994-01-12 1999-12-21 Brain Functions Laboratory, Inc. Method and apparatus for automatically determining somatic state
US5601090A (en) * 1994-07-12 1997-02-11 Brain Functions Laboratory, Inc. Method and apparatus for automatically determining somatic state
JP2540728B2 (en) * 1994-03-31 1996-10-09 株式会社脳機能研究所 Brain activity automatic determination device
US6081743A (en) * 1996-10-02 2000-06-27 Carter; John Leland Method and apparatus for treating an individual using electroencephalographic and cerebral blood flow feedback
DE19725214C1 (en) 1997-06-15 1998-11-19 Mario Dr Siebler Brain electricity measurement analyser
US6385486B1 (en) * 1997-08-07 2002-05-07 New York University Brain function scan system
US6931274B2 (en) * 1997-09-23 2005-08-16 Tru-Test Corporation Limited Processing EEG signals to predict brain damage
AU9368798A (en) * 1997-09-23 1999-04-12 Auckland Uniservices Limited Method and system for detecting white matter neural injury and predicting neurological outcome particularly for preterm infants
JPH11295746A (en) * 1998-02-16 1999-10-29 Sharp Corp Manufacture of liquid crystal element, liquid crystal filling device, and liquid crystal filling system
US6266556B1 (en) 1998-04-27 2001-07-24 Beth Israel Deaconess Medical Center, Inc. Method and apparatus for recording an electroencephalogram during transcranial magnetic stimulation
US6309361B1 (en) 1998-05-04 2001-10-30 Kirtley E. Thornton Method for improving memory by identifying and using QEEG parameters correlated to specific cognitive functioning
US6198958B1 (en) 1998-06-11 2001-03-06 Beth Israel Deaconess Medical Center, Inc. Method and apparatus for monitoring a magnetic resonance image during transcranial magnetic stimulation
US9375573B2 (en) 1998-08-05 2016-06-28 Cyberonics, Inc. Systems and methods for monitoring a patient's neurological disease state
US9042988B2 (en) 1998-08-05 2015-05-26 Cyberonics, Inc. Closed-loop vagus nerve stimulation
US7747325B2 (en) 1998-08-05 2010-06-29 Neurovista Corporation Systems and methods for monitoring a patient's neurological disease state
US9415222B2 (en) * 1998-08-05 2016-08-16 Cyberonics, Inc. Monitoring an epilepsy disease state with a supervisory module
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US9113801B2 (en) 1998-08-05 2015-08-25 Cyberonics, Inc. Methods and systems for continuous EEG monitoring
US6366797B1 (en) * 1998-08-25 2002-04-02 The Cleveland Clinic Foundation Method and system for brain volume analysis
US6821285B2 (en) 1999-06-22 2004-11-23 Ndo Surgical, Inc. Tissue reconfiguration
US7846180B2 (en) 1999-06-22 2010-12-07 Ethicon Endo-Surgery, Inc. Tissue fixation devices and methods of fixing tissue
US8287554B2 (en) * 1999-06-22 2012-10-16 Ethicon Endo-Surgery, Inc. Method and devices for tissue reconfiguration
US6663639B1 (en) 1999-06-22 2003-12-16 Ndo Surgical, Inc. Methods and devices for tissue reconfiguration
US6835200B2 (en) 1999-06-22 2004-12-28 Ndo Surgical. Inc. Method and devices for tissue reconfiguration
GB0003853D0 (en) * 2000-02-19 2000-04-05 Diagnostic Potentials Limited Method for investigating neurological function
WO2001093750A2 (en) * 2000-06-07 2001-12-13 Univ New York Methods for diagnosing and treating thalamocortical dysrhythmia
WO2002000095A2 (en) * 2000-06-26 2002-01-03 Avs Group, Inc. Treatment using electroencephalographic and cerebral blood flow feedback
US6488617B1 (en) * 2000-10-13 2002-12-03 Universal Hedonics Method and device for producing a desired brain state
US6463322B1 (en) 2001-04-10 2002-10-08 Viasys Healthcare, Inc. Combination referential and differential amplifier for medical signal monitoring
CA2446382A1 (en) * 2001-05-04 2002-11-14 University Of Virginia Patent Foundation Method, apparatus, and computer program product for assessment of attentional impairments
ES2316721T3 (en) * 2002-01-04 2009-04-16 Aspect Medical Systems, Inc. SYSTEMS AND PROCEDURE FOR THE EVALUATION OF DISORDERS OF THE STATE OF ANIMO USED EEG.
AU2003278801A1 (en) * 2002-09-13 2004-04-30 The Regents Of The University Of Michigan Noninvasive nonlinear systems and methods for predicting seizure
US7627078B2 (en) * 2002-11-08 2009-12-01 Ge Medical Systems Global Technology Company, Llc Methods and apparatus for detecting structural, perfusion, and functional abnormalities
AU2003902115A0 (en) * 2003-05-02 2003-05-22 The University Of Queensland Method of predicting functional outcome of a stroke using eeg measures
US7706871B2 (en) * 2003-05-06 2010-04-27 Nellcor Puritan Bennett Llc System and method of prediction of response to neurological treatment using the electroencephalogram
AU2004238259B2 (en) * 2003-05-06 2010-02-18 Covidien Lp System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram
US20050159671A1 (en) * 2003-12-18 2005-07-21 Sneddo & Associates Inc. Method for diagnosing, detecting, and monitoring brain function including neurological disease and disorders
US7761144B2 (en) * 2004-03-18 2010-07-20 University Of Virginia Patent Foundation Method, apparatus, and computer program product for stochastic psycho-physiological assessment of attentional impairments
JP2008526388A (en) * 2005-01-12 2008-07-24 アスペクト メディカル システムズ,インク. System and method for predicting adverse events during treatment of mental and neurological disorders
EP1885241B1 (en) * 2005-05-16 2016-06-22 Cerebral Diagnostics Canada Incorporated Near-real time three-dimensional localization, display , recording , and analysis of electrical activity in the cerebral cortex
WO2007065133A2 (en) * 2005-12-01 2007-06-07 Lexicor Medical Technology, Inc. Systems and methods for analyzing and assessing depression and other mood disorders using electroencephalographic (eeg) measurements
US8725243B2 (en) 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US20070224580A1 (en) * 2006-02-23 2007-09-27 Mcfaul William J Method for assessing a mental function activity profile
US20080027347A1 (en) 2006-06-23 2008-01-31 Neuro Vista Corporation, A Delaware Corporation Minimally Invasive Monitoring Methods
US8295934B2 (en) 2006-11-14 2012-10-23 Neurovista Corporation Systems and methods of reducing artifact in neurological stimulation systems
US9898656B2 (en) 2007-01-25 2018-02-20 Cyberonics, Inc. Systems and methods for identifying a contra-ictal condition in a subject
EP2124734A2 (en) 2007-01-25 2009-12-02 NeuroVista Corporation Methods and systems for measuring a subject's susceptibility to a seizure
US8036736B2 (en) 2007-03-21 2011-10-11 Neuro Vista Corporation Implantable systems and methods for identifying a contra-ictal condition in a subject
US8852216B2 (en) 2007-03-23 2014-10-07 Ethicon Endo-Surgery, Inc. Tissue approximation methods
US20080255582A1 (en) * 2007-04-11 2008-10-16 Harris John F Methods and Template Assembly for Implanting an Electrode Array in a Patient
KR100911731B1 (en) * 2007-07-18 2009-08-10 연세대학교 산학협력단 Cortical rhythmic activity monitering system based on EEG
US9788744B2 (en) 2007-07-27 2017-10-17 Cyberonics, Inc. Systems for monitoring brain activity and patient advisory device
US20090052279A1 (en) * 2007-08-21 2009-02-26 Charles Sicking Method and system for determining azimuth parameters for seismic data processing
US20090171168A1 (en) 2007-12-28 2009-07-02 Leyde Kent W Systems and Method for Recording Clinical Manifestations of a Seizure
US9259591B2 (en) 2007-12-28 2016-02-16 Cyberonics, Inc. Housing for an implantable medical device
US9713444B2 (en) 2008-09-23 2017-07-25 Digital Artefacts, Llc Human-digital media interaction tracking
US8849390B2 (en) 2008-12-29 2014-09-30 Cyberonics, Inc. Processing for multi-channel signals
US8588933B2 (en) 2009-01-09 2013-11-19 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US8786624B2 (en) 2009-06-02 2014-07-22 Cyberonics, Inc. Processing for multi-channel signals
AU2010286595A1 (en) * 2009-08-28 2012-02-23 NEBA Health, LLC. Systems and methods to identify a subgroup of ADHD at higher risk for complicating conditions
US9643019B2 (en) 2010-02-12 2017-05-09 Cyberonics, Inc. Neurological monitoring and alerts
US8532353B2 (en) * 2011-11-23 2013-09-10 Vital Images, Inc. Synthetic visualization and quantification of perfusion-related tissue viability
JP2013158591A (en) * 2012-02-08 2013-08-19 Kiyohara Optics Inc Smell generator
UA114504C2 (en) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс PCV, MYCOPLASMA HYOPNEUMONIA AND PRRS COMBINED VACCINE
WO2015052816A1 (en) * 2013-10-10 2015-04-16 株式会社島津製作所 Rehabilitation assistance system and brain function measurement unit
CA2857555A1 (en) 2014-04-01 2015-10-01 William F. Stubbeman Method and system for therapeutic brain stimulation using electromagnetic pulses
US10588534B2 (en) * 2015-12-04 2020-03-17 Colorado Seminary, Which Owns And Operates The University Of Denver Motor task detection using electrophysiological signals
WO2018165324A1 (en) * 2017-03-07 2018-09-13 The Regents Of The University Of California Method for monitoring treatment of neuropsychiatric disorders
US11723579B2 (en) 2017-09-19 2023-08-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11273283B2 (en) 2017-12-31 2022-03-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
EP3849410A4 (en) 2018-09-14 2022-11-02 Neuroenhancement Lab, LLC System and method of improving sleep
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
US20210307672A1 (en) 2020-04-05 2021-10-07 Epitel, Inc. Eeg recording and analysis
US11918368B1 (en) 2022-10-19 2024-03-05 Epitel, Inc. Systems and methods for electroencephalogram monitoring

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579125A (en) * 1984-01-23 1986-04-01 Cns, Inc. Real-time EEG spectral analyzer
US4800895A (en) * 1986-09-03 1989-01-31 Interspec, Inc. Electroencephalographic data display method and system
US4846190A (en) * 1983-08-23 1989-07-11 John Erwin R Electroencephalographic system data display

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4412547A (en) * 1981-04-29 1983-11-01 Neurologics, Inc. Neurological monitoring device
US4424816A (en) * 1981-04-29 1984-01-10 Neurologics, Inc. Neurological monitoring device test circuitry
US4557270A (en) * 1983-08-23 1985-12-10 New York University Electroencephalographic system for intra-operative open-heart surgery
US4649482A (en) * 1984-08-31 1987-03-10 Bio-Logic Systems Corp. Brain electrical activity topographical mapping
US4815474A (en) * 1987-04-13 1989-03-28 The Children's Medical Center Corporation Temporal trajectory analysis in brain electrical activity mapping
US4817627A (en) * 1987-08-07 1989-04-04 Cns, Inc. Electroencephalographic monitoring
US5010891A (en) * 1987-10-09 1991-04-30 Biometrak Corporation Cerebral biopotential analysis system and method
US5083571A (en) * 1988-04-18 1992-01-28 New York University Use of brain electrophysiological quantitative data to classify and subtype an individual into diagnostic categories by discriminant and cluster analysis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4846190A (en) * 1983-08-23 1989-07-11 John Erwin R Electroencephalographic system data display
US4579125A (en) * 1984-01-23 1986-04-01 Cns, Inc. Real-time EEG spectral analyzer
US4800895A (en) * 1986-09-03 1989-01-31 Interspec, Inc. Electroencephalographic data display method and system

Also Published As

Publication number Publication date
CA2115650A1 (en) 1993-03-04
EP0641175A4 (en) 1995-01-05
EP0641175A1 (en) 1995-03-08
US5269315A (en) 1993-12-14
WO1993003670A1 (en) 1993-03-04
AU2516192A (en) 1993-03-16
JPH06509730A (en) 1994-11-02
US5309923A (en) 1994-05-10

Similar Documents

Publication Publication Date Title
AU662760B2 (en) Determining brain activity including the nature of brain lesions by electroencephalography
Cook et al. Assessing the accuracy of topographic EEG mapping for determining local brain function
US5230346A (en) Diagnosing brain conditions by quantitative electroencephalography
Yang et al. Cognitive and neuropsychiatric correlates of EEG dynamic complexity in patients with Alzheimer's disease
Leuchter et al. Relationship between brain electrical activity and cortical perfusion in normal subjects
US6195576B1 (en) Quantitative magnetoencephalogram system and method
Knott et al. EEG power, frequency, asymmetry and coherence in male depression
McCarley et al. CT abnormalities in schizophrenia: A preliminary study of their correlations with P300/P200 electrophysiological features and positive/negative symptoms
Stufflebeam et al. Localization of focal epileptic discharges using functional connectivity magnetic resonance imaging
Faux et al. P300 topographic asymmetries are present in unmedicated schizophrenics
AU2012285379B2 (en) Method and system for estimating brain concussion
Cook et al. Synaptic dysfunction in Alzheimer's disease: clinical assessment using quantitative EEG
Cho et al. Clinical utility of interictal high-frequency oscillations recorded with subdural macroelectrodes in partial epilepsy
Frauscher et al. Sharply contoured theta waves are the human correlate of ponto-geniculo-occipital waves in the primary visual cortex
Jacobs et al. Spontaneous ripples in the hippocampus correlate with epileptogenicity and not memory function in patients with refractory epilepsy
Smith et al. Aiding diagnosis of attention‐deficit/hyperactivity disorder and its subtypes: discriminant function analysis of event‐related potential data
Schwartz et al. Magnetoencephalography
Edgar et al. Magnetoencephalography for schizophrenia
Tao et al. Coherence Characteristics of Gamma-band EEG during rest and cognitive task in MCI and AD
Pinner et al. Covariation between brain function (MEG) and structure (DTI) differentiates adolescents with fetal alcohol spectrum disorder from typically developing controls
Jeong et al. Localization of MEG pathologic gamma oscillations in adult epilepsy patients with focal cortical dysplasia
Abboud et al. High-frequency QRS electrocardiogram for diagnosing and monitoring ischemic heart disease
Mandelbaum et al. Topographic mapping of brain potentials in the newborn infant: the establishment of normal values and utility in assessing infants with neurological injury
US20220047204A1 (en) Methods, Computer-Readable Media and Devices for Producing an Index
Plutino et al. Inter-rater reliability of primitive signs in dementia

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired